Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5362-5368

  Rouxel, Agnès ^a,e   Hejblum, Gilles ^b,e   Bernier, Marie Odile ^a,b,e   Boëlle, Pierre Yves ^b,f   Ménégaux, Fabrice ^c,e   Mansour, George ^d,e   Hoang, Catherine ^d,e   Aurengo, André ^a,b,e   Leenhardt, Laurence ^a,b,e  

^a Serv Med Nucl   (France)

^b INSERM   (France)

^c Serv de Chir Gen et Digest   (France)

^d Serv d'Anat Cytologie P   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CANCER; MULTIVARIATE ANALYSIS; PAPILLOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THYROID CARCINOMA; THYROID FOLLICLE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; THYROID NEOPLASMS;

EID: 8744240542     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032004     Document Type: Article

References (43)

1. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424
2. Franceschi S, Boyle P, Maisonneuve P, La Vecchia C, Burt AD, Kerr DJ, MacFarlane GJ 1993 The epidemiology of thyroid carcinoma. Crit Rev Oncog 4:25-52
3. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428
4. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306
5. Sherman SI 2003 Thyroid carcinoma. Lancet 361:501-511
6. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463
7. Noguchi M, Yagi H, Earashi M, Kinoshita K, Miyazaki I, Mizukami Y 1995 Recurrence and mortality in patients with differentiated thyroid carcinoma. Int Surg 80:162-166
8. Ortiz S, Rodriguez JM, Parrilla P, Perez D, Moreno-Gallego A, Rios A, Soria T 2001 Recurrent papillary thyroid cancer: analysis of prognostic factors including the histological variant. Eur J Surg 167:406-412
9. Sugino K, Kure Y, Iwasaki H, Ozaki O, Mimura T, Matsumoto A, Ito K 1995 Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma. Surg Today 25:324-328
10. Asakawa H, Kobayashi T, Komoike Y, Tamaki Y, Matsuzawa Y, Monden M 1997 Prognostic factors in patients with recurrent differentiated thyroid carcinoma. J Surg Oncol 64:202-206
11. 131). Ann Surg 219:587-595
12. Kitamura Y, Shimizu K, Nagahama M, Sugino K, Ozaki O, Mimura T, Ito K, Tanaka S 1999 Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 84:4043-4049
13. Hay ID 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545-576
14. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF 1986 Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 61:978-996
15. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM 1988 Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 104:954-962
16. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C 1985 Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794-804
17. Samaan NA, Schulte PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG 1992 The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720
18. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058
19. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998 A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83:2638-2648
20. Stojadinovic A, Shoup M, Nissan A, Ghossein RA, Shah JP, Brennan MF, Shaha AR 2002 Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence. Ann Surg Oncol 9:789-798
21. Krausz Y, Uziely B, Karger H, Isacson R, Catane R, Glaser B 1993 Recurrence-associated mortality in patients with differentiated thyroid carcinoma. J Surg Oncol 52:164-168
22. Vassilopoulou-Sellin R, Schultz PN, Haynie TP 1996 Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 78:493-501
23. American Joint Committee on Cancer 2002 TNM classification of malignant tumors. In: Greene FL, Balch CM, Fleming ID, Fritz A, Haller DG, Morrow M, Page DL, eds. Cancer staging handbook. 6th ed. New York: Springer; 469
24. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M 2000 Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175-178
25. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E, Lind P, Pacini F, Reiners C, Sanchez Franco F, Toft A, Wiersinga WM 2004 Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 150:105-112
26. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R 2003 Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90-96
27. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A 2003 Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88:3668-3673
28. Faris PD, Ghali WA, Brant R, Norris CM, Galbraith PD, Knudtson ML 2002 Multiple imputation versus data enhancement for dealing with missing data in observational health care outcome analyses. J Clin Epidemiol 55:184-191
29. Van Buuren S, Boshuizen HC, Knook DL 1999 Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18:681-694
30. R Development CoreTeam 2003 R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing (http://www.R- project.org)
31. Hamby LS, McGrath PC, Schwartz RW, Sloan DA, Simpson WG, Kenady DE 1992 Management of local recurrence in well-differentiated thyroid carcinoma. J Surg Res 52:113-117
32. Mirallie E, Hamy A, Floch I, Sagan C, Paineau J, Murat A, Le Neel JC, Visset J 1999 [Outcome in cervical recurrences of papillary or follicular thyroid cancer]. Ann Chir 53:577-582 (French)
33. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR 1998 Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 124:958-966
34. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS 1994 Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 18:123-130
35. Savoie J, Massin J 1977 Outline for the treatment of differentiated thyroid carcinomas by total thyroidectomy and complementary radioiodine. Ann Radiol 20:822-825
36. Hedinger CE, Williams ED, Sobin LH 1988 Histological typing of thyroid tumours. 2nd ed. Berlin, New York: Springer-Verlag
37. Renshaw AA, Gould EW 2002 Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 117:19-21
38. Lin KD, Lin JD, Huang MJ, Huang HS, Jeng LB, Chao TC, Ho YS 1997 Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg 82:378-381
39. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB 1988 Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14:1063-1075
40. Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G 2001 Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568-1573
41. 99mTc MIBI scan combined with high resolution neck ultrasonography. Tumori 85:122-127
42. 131I-negative papillary thyroid carcinoma. J Nucl Med 41:1010-1015
43. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR 2002 Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879-885